Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.305 USD | +1.95% | +1.57% | -14.00% |
08/05 | Transcript : Immunic, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Immunic, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.00% | 115M | |
+6.63% | 111B | |
+11.45% | 106B | |
-12.71% | 22.24B | |
-0.09% | 21.25B | |
-4.64% | 18.97B | |
-35.21% | 18.52B | |
-10.58% | 16.81B | |
+37.78% | 12.54B | |
-25.27% | 8.09B |
- Stock Market
- Equities
- IMUX Stock
- News Immunic, Inc.
- Immunic Says Phase 2 Trial Reinforces Vidofludimus Calcium's Neuroprotective Potential; Shares Soar Premarket